Literature DB >> 20919937

Hydrogen peroxide regulates extracellular superoxide dismutase activity and expression in neonatal pulmonary hypertension.

Stephen Wedgwood1, Satyan Lakshminrusimha, Tohru Fukai, James A Russell, Paul T Schumacker, Robin H Steinhorn.   

Abstract

We previously demonstrated that superoxide and H(2)O(2) promote pulmonary arterial vasoconstriction in a lamb model of persistent pulmonary hypertension of the newborn (PPHN). Because extracellular superoxide dismutase (ecSOD) augments vasodilation, we hypothesized that H(2)O(2)-mediated ecSOD inactivation contributes to pulmonary arterial vasoconstriction in PPHN lambs. ecSOD activity was decreased in pulmonary arterial smooth muscle cells (PASMCs) isolated from PPHN lambs relative to controls. Exposure to 95% O(2) to mimic hyperoxic ventilation reduced ecSOD activity in control PASMCs. In both cases, these events were associated with increased protein thiol oxidation, as detected by the redox sensor roGFP. Accordingly, exogenous H(2)O(2) decreased ecSOD activity in control PASMCs, and PEG-catalase restored ecSOD activity in PPHN PASMCs. In intact animal studies, ecSOD activity was decreased in fetal PPHN lambs, and in PPHN lambs ventilated with 100% O(2) relative to controls. In ventilated PPHN lambs, administration of a single dose of intratracheal PEG-catalase enhanced ecSOD activity, reduced superoxide levels, and improved oxygenation. We propose that H(2)O(2) generated by PPHN and hyperoxia inactivates ecSOD, and intratracheal catalase enhances enzyme function. The associated decrease in extracellular superoxide augments vasodilation, suggesting that H(2)O(2) scavengers may represent an effective therapy in the clinical management of PPHN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20919937      PMCID: PMC3151423          DOI: 10.1089/ars.2010.3630

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  47 in total

1.  Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators.

Authors:  George T Hanson; Robert Aggeler; Devin Oglesbee; Mark Cannon; Roderick A Capaldi; Roger Y Tsien; S James Remington
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

2.  Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators.

Authors:  Colette T Dooley; Timothy M Dore; George T Hanson; W Coyt Jackson; S James Remington; Roger Y Tsien
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme.

Authors:  E K Hodgson; I Fridovich
Journal:  Biochemistry       Date:  1975-12-02       Impact factor: 3.162

Review 5.  Neonatal pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

6.  Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group.

Authors:  R H Clark; T J Kueser; M W Walker; W M Southgate; J L Huckaby; J A Perez; B J Roy; M Keszler; J P Kinsella
Journal:  N Engl J Med       Date:  2000-02-17       Impact factor: 91.245

7.  Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase.

Authors:  Lisa A Brennan; Robin H Steinhorn; Stephen Wedgwood; Eugenia Mata-Greenwood; Everett A Roark; James A Russell; Stephen M Black
Journal:  Circ Res       Date:  2003-02-27       Impact factor: 17.367

8.  Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity.

Authors:  H Ulrich Hink; Nalini Santanam; Sergey Dikalov; Louise McCann; Andrew D Nguyen; Sampath Parthasarathy; David G Harrison; Tohru Fukai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-09-01       Impact factor: 8.311

9.  Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice.

Authors:  Oliver Jung; Stefan L Marklund; Helmut Geiger; Thierry Pedrazzini; Rudi Busse; Ralf P Brandes
Journal:  Circ Res       Date:  2003-08-21       Impact factor: 17.367

10.  A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure.

Authors:  G Ganesh Konduri; Alfonso Solimano; Gregory M Sokol; Joel Singer; Richard A Ehrenkranz; Nalini Singhal; Linda L Wright; Krisa Van Meurs; Eileen Stork; Haresh Kirpalani; Abraham Peliowski
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

View more
  32 in total

Review 1.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

2.  Pulmonary artery endothelial cell dysfunction and decreased populations of highly proliferative endothelial cells in experimental congenital diaphragmatic hernia.

Authors:  Shannon N Acker; Gregory J Seedorf; Steven H Abman; Eva Nozik-Grayck; David A Partrick; Jason Gien
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-11       Impact factor: 5.464

Review 3.  Role of reactive oxygen species in neonatal pulmonary vascular disease.

Authors:  Stephen Wedgwood; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 4.  Factors relating caesarean section to persistent pulmonary hypertension of the newborn.

Authors:  Niralee Babooa; Wen-Jing Shi; Chao Chen
Journal:  World J Pediatr       Date:  2017-10-20       Impact factor: 2.764

Review 5.  Therapeutic approaches using nitric oxide in infants and children.

Authors:  Robin H Steinhorn
Journal:  Free Radic Biol Med       Date:  2011-01-13       Impact factor: 7.376

6.  Targeting mitochondrial reactive oxygen species to modulate hypoxia-induced pulmonary hypertension.

Authors:  Sherry E Adesina; Bum-Yong Kang; Kaiser M Bijli; Jing Ma; Juan Cheng; Tamara C Murphy; C Michael Hart; Roy L Sutliff
Journal:  Free Radic Biol Med       Date:  2015-06-12       Impact factor: 7.376

7.  Reactive oxygen species-reducing strategies improve pulmonary arterial responses to nitric oxide in piglets with chronic hypoxia-induced pulmonary hypertension.

Authors:  Candice D Fike; Anna Dikalova; James C Slaughter; M R Kaplowitz; Y Zhang; Judy L Aschner
Journal:  Antioxid Redox Signal       Date:  2013-01-29       Impact factor: 8.401

8.  Increased p22(phox)/Nox4 expression is involved in remodeling through hydrogen peroxide signaling in experimental persistent pulmonary hypertension of the newborn.

Authors:  Stephen Wedgwood; Satyan Lakshminrusimha; Lyubov Czech; Paul T Schumacker; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2013-02-15       Impact factor: 8.401

9.  Chronic hypoxia limits H2O2-induced inhibition of ASIC1-dependent store-operated calcium entry in pulmonary arterial smooth muscle.

Authors:  Danielle R Plomaritas; Lindsay M Herbert; Tracylyn R Yellowhair; Thomas C Resta; Laura V Gonzalez Bosc; Benjimen R Walker; Nikki L Jernigan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-03       Impact factor: 5.464

10.  Isolation of pulmonary artery smooth muscle cells from neonatal mice.

Authors:  Keng Jin Lee; Lyubov Czech; Gregory B Waypa; Kathryn N Farrow
Journal:  J Vis Exp       Date:  2013-10-19       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.